Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Case Reports in Pediatrics
Volume 2015, Article ID 818961, 4 pages
http://dx.doi.org/10.1155/2015/818961
Case Report

Netherton Syndrome in a Neonate with Possible Growth Hormone Deficiency and Transient Hyperaldosteronism

12nd Neonatal Intensive Care Unit, G.P.N. Papageorgiou Hospital, Aristotle University Faculty of Medicine, Agias Triados 3B Street, Pefka, 57010 Thessaloniki, Greece
22nd Dermatology Department, G.P.N. Papageorgiou Hospital, Aristotle University Faculty of Medicine, Thessaloniki, Greece
34th Department of Pediatrics, G.P.N. Papageorgiou Hospital, Aristotle University Faculty of Medicine, Thessaloniki, Greece
4Laboratory of Genetics, Evolutionary & Comparative Biology, Biochemistry & Biotechnology Department, University of Thessaly, Larissa, Greece

Received 7 March 2015; Revised 24 May 2015; Accepted 26 May 2015

Academic Editor: Pietro Strisciuglio

Copyright © 2015 Chatziioannidis Ilias et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Sun and K. G. Linden, “Netherton syndrome: a case report and review of the literature,” International Journal of Dermatology, vol. 45, no. 6, pp. 693–697, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Fraitag and C. Bodemer, “Neonatal erythroderma,” Current Opinion in Pediatrics, vol. 22, no. 4, pp. 438–444, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Chavanas, C. Bodemer, A. Rochat et al., “Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome,” Nature Genetics, vol. 25, no. 2, pp. 141–142, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Komatsu, K. Saijoh, A. Jayakumar et al., “Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients,” Journal of Investigative Dermatology, vol. 128, no. 5, pp. 1148–1159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Bitoun, S. Chavanas, A. D. Irvine et al., “Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families,” Journal of Investigative Dermatology, vol. 118, no. 2, pp. 352–361, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Capri, P. Vanlieferinghen, B. Boeuf, P. Dechelotte, A. Hovnanian, and B. Lecomte, “A lethal variant of Netherton syndrome in a large inbred family,” Archives de Pediatrie, vol. 18, no. 3, pp. 294–298, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Lacroix, L. Lacaze-Buzy, L. Furio et al., “Clinical expression and new SPINK5 splicing defects in netherton syndrome: unmasking a frequent founder synonymous mutation and unconventional intronic mutations,” Journal of Investigative Dermatology, vol. 132, no. 3, pp. 575–582, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Sprecher, S. Chavanas, J. J. DiGiovanna et al., “The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis,” Journal of Investigative Dermatology, vol. 117, no. 2, pp. 179–187, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Fortugno, L. Furio, M. Teson et al., “The 420k LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis,” Human Molecular Genetics, vol. 21, no. 19, Article ID dds243, pp. 4187–4200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. B. K. Aydın, F. Baş, Z. Tamay et al., “Netherton syndrome associated with growth hormone deficiency,” Pediatric Dermatology, vol. 31, no. 1, pp. 90–94, 2014. View at Publisher · View at Google Scholar · View at Scopus